A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics
Latest Information Update: 07 Dec 2021
At a glance
- Drugs Quetmolimab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 26 Feb 2020 Status changed from active, no longer recruiting to completed.
- 15 Oct 2019 Planned End Date changed from 1 Dec 2019 to 1 Jan 2020.
- 15 Jun 2019 Results from first 12 weeks presented at the 20th Annual Congress of the European League Against Rheumatism